Antonio Jesus Blanco
Research group
- Pathogenesis and treatment of autoimmunity Pre-doctoral researcher (R1)
Featured publications
-
Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit
Authors:Reference: Endocrinologia Diabetes Y Nutricion 2019. -
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Authors:Reference: Nature Communications 2019. -
Vitamin E supplementation for adults with diabetes mellitus
Authors:Reference: Cochrane Database Syst Rev 2014. -
Relating with monographic «Actualización terapéutica para el tratamiento de la diabetes tipo 2»
Authors:Reference: Endocrinologia Y Nutricion 2013. -
Why should we be concerned about diagnosing a monogenic form of diabetes?
Authors:Reference: Sulforaphane Protects Sk-N-Sh Cells Against Antipsychotic-Induced Oxidative Stress 2013. -
As regards the Special Issue on insulin aspart [En relación con el número extraordinario monográfico sobre insulina aspártica]
Authors:Reference: Avances En Diabetologia 2012. -
Reply to «i remember you Amanda (and Antonio J.)» [Réplica a «te recuerdo Amanda (y Antonio J.)»]
Authors:Reference: Avances En Diabetologia 2012. -
Why should I choose or not choose to be trained as a specialist in Endocrinology and Nutrition again? [¿Por qué volvería o por qué no volvería a elegir formarme como especialista en Endocrinología y Nutrición?]
Authors:Reference: Avances En Diabetologia 2012.
Featured Projects
-
Nuevas nanomedicinas para el tratamiento de la Diabetes tipo 1: modulando las redes regulatorias anti-diabetogénicas de linfocitos T y B
Funder: Fundación Clínic (Sede o evento); Sociedad Española de DiabetesDuration: 01/05/2013 - 01/05/2014 -
New nanomedicines for the treatment of autoimmune diseases
Funder: Institut de Investigacions Biomèdiques Augist Pi i Sunyer (Sede o evento); European Foundation for the Study of DiabetesDuration: 01/01/2013 - 01/01/2016 -
Utilidad del uso de biomarcadores en el diagnóstico de pacientes con MODY3
Funder: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); HOSPITAL CLINICO Y PROVINCIAL DE BARCELONADuration: 01/06/2011 - 01/12/2012 -
Collaborative European Effort to Develop Diabetes Diagnosis (CEED3)
Funder: Institut de Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Unión Europea (Integrated project, 22321).Duration: 01/12/2008 - 03/11/2012